Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.

Inclusion Criteria: * Provide written informed consent * Subjects age \> 21 and \< 95 years at the time of signing the Informed Consent Form. * Each subject must have endothelial dysfunction. Endothelial dysfunction Criteria: Impaired flow-mediated vasodilation (FMD \<7%) • At the time of enrollment, each subject must meet at least 3 out of the 5 criteria under the harmonized definition of the metabolic syndrome, consisting of the following: * Waist circumference - US defined: ≥ 102 cm (males) or ≥ 88 cm (females) * Elevated triglycerides - ≥ 150 mg/dL (1.7 mM) * Reduced HDL-C - Males: \<40 mg/dL (1.0 mM) Females: \<50 mg/dL (1.3 mM) * Elevated blood pressure - Systolic ≥ 130 mm Hg and/or Diastolic ≥ 85 mm Hg * Elevated fasting glucose - ≥ 100 mg/dL Exclusion Criteria: * Be a female who is pregnant, nursing, or of childbearing potential while not practicing effective contraceptive methods. Female subjects must undergo a blood or urine pregnancy test at screening and within 36 hours prior to infusion. * Inability to perform any of the assessments required for endpoint analysis. * Active listing (or expected future listing) for transplant of any organ. * Clinically important abnormal screening laboratory values, as determined by the P.I. * Serious comorbid illness or any other condition that, in the opinion of the investigator, may compromise the safety or compliance of the subject or preclude successful completion of the study. * Have known allergies to penicillin or st…